Alzheimer’s disease and dementia research are advancing the understanding, diagnosis, and treatment of neurodegenerative disorders that affect millions worldwide. Advances in amyloid and tau biology, molecular biomarkers, neuroimaging, and cognitive assessment are enabling earlier diagnosis and more accurate disease monitoring. Researchers are developing innovative therapeutic strategies to slow disease progression and improve cognitive function and quality of life. The integration of precision medicine, digital technologies, and biomarker-guided interventions continues to transform dementia care, supporting better clinical outcomes and the development of next-generation treatments.
